Clinical trial
Effect of Tirzepatide on Functional Outcomes in Patients With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy: A Multicenter, Randomized, Controlled, Blinded Outcome Assessment Trial
NCT07734792 is registered in ClinicalTrials.gov with yifang zhu as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Tirzepatide on Functional Outcomes in Patients With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy: A Multicenter, Randomized, Controlled, Blinded Outcome Assessment Trial
- Lead sponsor
- yifang zhu
- Phase
- Phase 2/3
- Overall status
- Not yet recruiting
- Start date
- September 20, 2026
- Completion date
- July 31, 2028
- Enrollment
- 726 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute ischemic stroke (ais)